In search of the vulnerable patient or the vulnerable plaque: F-sodium fluoride positron emission tomography for cardiovascular risk stratification

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) remains a leading cause of death. Preventative therapies that reduce CVD are most effective when targeted to individuals at high risk. Current risk stratification tools have only modest prognostic capabilities, resulting in over-treatment of low-risk individuals and under-treatment of high-risk individuals. Improved methods of CVD risk stratification are required. Molecular imaging offers a novel approach to CVD risk stratification. In particular, 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) has shown promise in the detection of both high-risk atherosclerotic plaque features and vascular calcification activity, which predicts future development of new vascular calcium deposits. The rate of change of coronary calcium scores, measured by serial computed tomography scans over a 2-year period, is a strong predictor of CVD risk. Vascular calcification activity, as measured with 18F-NaF PET, has the potential to provide prognostic information similar to consecutive coronary calcium scoring, with a single-time-point convenience. However, owing to the rapid motion and small size of the coronary arteries, new solutions are required to address the traditional limitations of PET imaging. Two different methods of coronary PET analysis have been independently proposed and here we compare their respective strengths, weaknesses, and the potential for clinical translation.

Original languageEnglish
Pages (from-to)1774-1783
JournalJournal of Nuclear Cardiology
Volume25
Issue number5
DOIs
Publication statusE-pub ahead of print - 10 Jul 2018

Fingerprint

Sodium Fluoride
Positron-Emission Tomography
Cardiovascular Diseases
Vascular Calcification
Calcium
Molecular Imaging
Atherosclerotic Plaques
Blood Vessels
Cause of Death
Coronary Vessels
Therapeutics
Tomography

Cite this

@article{ce245d8a10d34f839da8484bdffdc028,
title = "In search of the vulnerable patient or the vulnerable plaque: F-sodium fluoride positron emission tomography for cardiovascular risk stratification",
abstract = "Cardiovascular disease (CVD) remains a leading cause of death. Preventative therapies that reduce CVD are most effective when targeted to individuals at high risk. Current risk stratification tools have only modest prognostic capabilities, resulting in over-treatment of low-risk individuals and under-treatment of high-risk individuals. Improved methods of CVD risk stratification are required. Molecular imaging offers a novel approach to CVD risk stratification. In particular, 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) has shown promise in the detection of both high-risk atherosclerotic plaque features and vascular calcification activity, which predicts future development of new vascular calcium deposits. The rate of change of coronary calcium scores, measured by serial computed tomography scans over a 2-year period, is a strong predictor of CVD risk. Vascular calcification activity, as measured with 18F-NaF PET, has the potential to provide prognostic information similar to consecutive coronary calcium scoring, with a single-time-point convenience. However, owing to the rapid motion and small size of the coronary arteries, new solutions are required to address the traditional limitations of PET imaging. Two different methods of coronary PET analysis have been independently proposed and here we compare their respective strengths, weaknesses, and the potential for clinical translation.",
author = "Bellinge, {Jamie W} and Francis, {Roslyn J} and Kamran Majeed and Watts, {Gerald F} and Schultz, {Carl J}",
year = "2018",
month = "7",
day = "10",
doi = "10.1007/s12350-018-1360-2",
language = "English",
volume = "25",
pages = "1774--1783",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer",
number = "5",

}

TY - JOUR

T1 - In search of the vulnerable patient or the vulnerable plaque

T2 - F-sodium fluoride positron emission tomography for cardiovascular risk stratification

AU - Bellinge, Jamie W

AU - Francis, Roslyn J

AU - Majeed, Kamran

AU - Watts, Gerald F

AU - Schultz, Carl J

PY - 2018/7/10

Y1 - 2018/7/10

N2 - Cardiovascular disease (CVD) remains a leading cause of death. Preventative therapies that reduce CVD are most effective when targeted to individuals at high risk. Current risk stratification tools have only modest prognostic capabilities, resulting in over-treatment of low-risk individuals and under-treatment of high-risk individuals. Improved methods of CVD risk stratification are required. Molecular imaging offers a novel approach to CVD risk stratification. In particular, 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) has shown promise in the detection of both high-risk atherosclerotic plaque features and vascular calcification activity, which predicts future development of new vascular calcium deposits. The rate of change of coronary calcium scores, measured by serial computed tomography scans over a 2-year period, is a strong predictor of CVD risk. Vascular calcification activity, as measured with 18F-NaF PET, has the potential to provide prognostic information similar to consecutive coronary calcium scoring, with a single-time-point convenience. However, owing to the rapid motion and small size of the coronary arteries, new solutions are required to address the traditional limitations of PET imaging. Two different methods of coronary PET analysis have been independently proposed and here we compare their respective strengths, weaknesses, and the potential for clinical translation.

AB - Cardiovascular disease (CVD) remains a leading cause of death. Preventative therapies that reduce CVD are most effective when targeted to individuals at high risk. Current risk stratification tools have only modest prognostic capabilities, resulting in over-treatment of low-risk individuals and under-treatment of high-risk individuals. Improved methods of CVD risk stratification are required. Molecular imaging offers a novel approach to CVD risk stratification. In particular, 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) has shown promise in the detection of both high-risk atherosclerotic plaque features and vascular calcification activity, which predicts future development of new vascular calcium deposits. The rate of change of coronary calcium scores, measured by serial computed tomography scans over a 2-year period, is a strong predictor of CVD risk. Vascular calcification activity, as measured with 18F-NaF PET, has the potential to provide prognostic information similar to consecutive coronary calcium scoring, with a single-time-point convenience. However, owing to the rapid motion and small size of the coronary arteries, new solutions are required to address the traditional limitations of PET imaging. Two different methods of coronary PET analysis have been independently proposed and here we compare their respective strengths, weaknesses, and the potential for clinical translation.

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85049674943&origin=resultslist&sort=plf-f&src=s&st1=In+search+of+the+vulnerable+patient+or+the+vulnerable+plaque%3a+18F-sodium+fluoride+positron+emission+tomography+for+cardiovascular+risk+stratification&st2=&sid=65070d18a1d44c8253beb75326dd335c&sot=b&sdt=b&sl=164&s=TITLE-ABS-KEY%28In+search+of+the+vulnerable+patient+or+the+vulnerable+plaque%3a+18F-sodium+fluoride+positron+emission+tomography+for+cardiovascular+risk+stratification%29&relpos=0&citeCnt=0&searchTerm=

U2 - 10.1007/s12350-018-1360-2

DO - 10.1007/s12350-018-1360-2

M3 - Review article

VL - 25

SP - 1774

EP - 1783

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

SN - 1071-3581

IS - 5

ER -